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Previously, model systems were developed in our laboratory to study murine immune responses to the
23-valent pneumococcal polysaccharide vaccine Pnu-Imune, both in vivo and in vitro (M. Garg and B.
Subbarao, Infect. Immun. 60:2329–2336, 1992; M. Garg, A. M. Kaplan, and S. Bondada, J. Immunol. 152:
1589–1596, 1994). Using these systems, we found that aged mice did not respond to the vaccine in vivo or in
vitro. Cell separation studies showed that the unresponsiveness of the aged spleen cells to the vaccine was not
due to an intrinsic B-cell defect or to T-cell-mediated immunosuppression but resulted from an accessory cell
deficiency. Irradiated spleen cells from young mice enabled the old mouse spleen cells to respond to the vaccine.
Interestingly, irradiated spleen cells from old mice also restored the vaccine responsiveness in old mice but
were required in greater numbers than the young mouse spleen cells to induce similar levels of response. The
accessory cell was an adherent cell that could be removed by passage through Sephadex G-10 and thus may be
a macrophage. Accessory function could also be provided by the cytokine interleukin-1 (IL-1), IL-4, or IL-5 but
not IL-2 or IL-6. Thus, one reason for the deficient immune response to pneumococcal vaccine in aged mice is
a quantitative defect in adherent accessory cells.
Immune responses are decreased in the aged, resulting in an
increased incidence of infections in the elderly (43, 45, 58). The
thymus atrophies with age, and T cells exhibit a number of
abnormalities such as reduced interleukin-2 (IL-2) secretion
but an increased production of IL-6 and gamma interferon
(IFN-g) (12, 14, 19, 32, 41). Although a decline in T-cell func-
tion is the major cause of reduced immune function in the
aged, B cells and macrophages also function less effectively in
the elderly (21, 26, 46, 56). Thus, B cells from aged mice
proliferated poorly in response to stimulation with activated T
cells (36, 53) or with anti-m plus IL-4 (55) and were less sus-
ceptible to tolerance induction (59). Also, fewer B cells were
generated from bone marrow precursors in the aged, but nei-
ther the B-cell repertoire nor their life span was altered sub-
stantially (27, 57, 60, 61).
One of the major consequences of the senescent immune
system is an increased incidence of pneumococcal pneumonia,
which is a leading cause of death in the elderly (2, 28). More-
over, there has been an increase in the occurrence of antibi-
otic-resistant pneumococcal bacteria (37). Serum antibodies to
the capsular polysaccharides (PS) of the pneumococcal bacte-
ria provide protection against the pneumococci, but such an-
tibodies are not present at sufficient levels in the aged (2, 20,
28). A vaccine, made up of purified capsular PS from 23 com-
monly occurring serotypes of pneumococcal bacteria, was de-
veloped to increase the levels of circulating antibodies to pneu-
mococcal bacteria in older people (10). The efficacy of this
vaccine in the elderly has been extremely variable (9, 47, 49),
and it was ineffective in small children (5) as well as in patients
with AIDS (48). However, the precise mechanisms underlying
the poor immunogenicity of the vaccine in these populations
have thus far not been elucidated.
Recently we developed a murine model with which to study
the cellular basis of immune response to the pneumococcal PS
vaccine (17, 18), using the whole vaccine as immunogen and
vaccine-coupled sheep erythrocytes (SRBC) to detect anti-
body-secreting cells (18). This system measured antibody re-
sponses to 21 of 23 PS in the vaccine, and the responses
measured with the whole vaccine were 50% as efficient as with
the individual PS (18). The murine model system also exhibited
an age-associated decline in the immune response to the vac-
cine, which was consistent with the previously reported de-
creased responsiveness of the aged to type III pneumococcal
PS (51). The responses of the old mice to the vaccine were
substantially enhanced by the adjuvant, monophosphoryl lipid
A (MPL), and the steroid hormone dihydroxy epiandrosterone
(DHEA), agents that have been shown to respectively stimu-
late accessory function and alter cytokine secretion patterns
from T cells (1, 14, 16, 18, 42). Also, our studies showed that
spleen and mesenteric lymph nodes but not peripheral lymph
nodes responded to the vaccine, which is consistent with the
well-known splenic dependence of the antibody response to
pneumococcal PS (2, 18).
Using a recently established in vitro culture system to repro-
ducibly obtain vaccine-specific immune responses, we showed
that the vaccine induced a good response without T cells but
was regulated by T-cell-derived lymphokines (17). Thus, IL-5
enhanced the vaccine response whereas IFN-g inhibited the
vaccine response. Further, the in vitro system replicated the in
vivo findings concerning the differential ability of spleen and
lymph node B cells to respond to the vaccine. The unrespon-
siveness of the lymph node cells to the vaccine was due to a
deficiency in accessory cell function which could be reconsti-
tuted by splenic adherent cells (17). Many characteristics of the
vaccine response are similar to those of trinitrophenyl (TNF)–
aminoethyl-carboxymethyl-Ficoll (Ficoll), a prototype of type 2
T-independent (TI) antigens, but unlike TNP-Ficoll, acute de-
pletion of T cells did not diminish the in vitro vaccine response.
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Because of this and other differences such as the susceptibility
to regulatory T cells, we have classified TNP-Ficoll as a TI-2A
antigen and vaccine and other pneumococcal PS as TI-2B
antigens (6).
Although the phenomenon of age-associated decline in an-
tibody response to the pneumococcal PS in humans as well as
mice has been known for over 25 years, the cellular basis of this
defect has not been precisely defined because of a lack of good
in vitro systems. In this study, we used our recently developed
in vitro model system to investigate the cellular basis of the
decreased vaccine response in the aged. We found that the
hyporesponsiveness of the aged to the vaccine was due not to
an increase in T-cell-mediated suppressive influences but to a
lack of accessory cell function. The response of the aged mouse
spleen cells was restored by supplementation with accessory
cells from young mice or a variety of cytokines such as IL-1,
IL-4, and IL-5.
MATERIALS AND METHODS
Mice. Young (14- to 22-week-old) and old (20- to 26-month-old) BALB/c mice
as well as mice of intermediate ages were obtained from the National Institute of
Aging through Charles River Laboratories and Sprague Daley. Old mice that
had tumors or splenomegaly or were weak or sick were excluded from all
analyses. About 10 to 20% of the old mice had such characteristics, which
required their elimination from the study, whereas none of the young mice
exhibited such properties.
Reagents. Pnu-Immune 23, a 23-valent pneumococcal vaccine, was obtained
from Lederle Laboratories, Pearl River, N.Y. TNP-Brucella abortus was pre-
pared as described before (25). TNP-Ficoll was a kind gift from John Inman,
National Institutes of Health, Bethesda, Md. Recombinant-derived human IL-1
and murine IL-2 were obtained from Genzyme Corp. (Boston, Mass.). Recom-
binant-derived murine IL-4 and murine IL-5 were obtained as supernatants from
HeLa cells transfected with specific genes, and the transfected cell lines were
obtained from T. Honjo, Kyoto University, and Kim Bottomly, Yale University.
In some experiments, purified IL-4 and IL-5 (Genzyme) were used. Supernatant
from a turkey gamma globulin-specific Th2 type of helper cell line (TGG Sup)
was obtained from Don Cohen, University of Kentucky. It contained IL-4 and
IL-5 but no detectable IL-2 activity, and the lymphokines were partially purified
by ammonium sulfate precipitation (11). Purified recombinant murine IL-6 was
a kind gift of the Genetics Institute (Boston, Mass.).
Preparation of cells. Spleen cells from unimmunized mice were obtained by
teasing the spleens by compression with a syringe plunger on a petri dish in
Hanks balanced salt solution. The spleen cells were allowed to settle for 2 min to
settle any debris, and the supernatant was centrifuged at 400 3 g to obtain
lymphocytes. The lymphocytes were washed twice with Hanks balanced salt
solution before use and were suspended in tissue culture medium described
below. The tissue culture medium, shown to support in vitro responses from B
cells, consisted of a 1:1 mixture of Iscove’s modified Dulbecco’s medium and
Ham’s F12 medium supplemented with L-glutamine, 2-mercaptoethanol, insulin,
transferrin, progesterone, trace elements, and gentamicin as described by Mosier
(35) and Subbarao and Mosier (52) (IF12 medium) plus 10% fetal calf serum
(FCS; HyClone Laboratories, Logan, Utah).
Spleen cells were depleted of adherent accessory cells by adhering to plastic
for 1 h and passage of the nonadherent cells through Sephadex G-10 columns as
described by Ly and Mishell (30). T cells were removed by treating spleen cells
with monoclonal antibodies (MAbs) to the Thy 1.2, CD4, and CD8 antigens plus
agarose-adsorbed rabbit complement (PelFreeze Laboratories) once or twice as
described by us previously (18, 25). The proliferative response of the T-cell-
depleted spleen cells to the T-cell mitogen concanavalin A was decreased by 95
to 99%. Spleen cells before and after depletion of T or adherent cells were
irradiated at 3,000 rads with g rays from a 137Cs source whenever they were used
as a source of accessory cells. Such irradiated cells were tested routinely for a
vaccine response by culturing them with an optimal dose of the vaccine and were
found to be completely unresponsive.
Adherent accessory cells were obtained by the procedure described by us
previously (17). Spleen cells, suspended in IF12–1% FCS, were incubated in a
tissue culture flask in a 5% CO2 atmosphere at 378C for 1 h, and the nonadherent
cells were removed by aspiration. The remaining cells were incubated for another
30 min, and the nonadherent cells were removed. Fresh medium was added to
the flask, and incubation was continued overnight to remove dendritic cells,
which become nonadherent during this period. The adherent cells were collected
from the flask by treatment with 2 mM EDTA in phosphate-buffered saline
(PBS) for 5 min. The cells were washed twice with PBS and were used for flow
cytometry or as accessory cells.
Flow cytometric measurement of phagocytic cells. The spleen cells or acces-
sory cells (106/ml) were resuspended in RPMI–1% FCS and exposed to fluores-
cent latex bead suspension (Polyscience Inc., Warrington, Pa.) for 30 min at 378C
in a water bath. The cells were separated from free beads by being washed twice
with cold 2 mM EDTA–PBS buffer and were analyzed on a FACScan flow
cytometer (Becton Dickinson, Mountain View, Calif.). The cells that took up the
latex beads appear as sharp peaks with very high fluorescence intensity. The
number of Mac-1-positive cells was determined by staining with rat anti-mouse
Mac-1 MAb plus fluorescein isothiocyanate-conjugated goat anti-rat immuno-
globulin G (Southern Biotechnology Associates, Birmingham, Ala.).
In vitro culture conditions. The culture conditions were the same as described
before (17). Briefly, 2 million spleen cells from young or old mice were cultured
in triplicate with or without the indicated doses of antigen in 1.0 ml of IF12–5%
FCS in 24-well Costar (Cambridge, Mass.) dishes for 5 days, or as indicated, at
378C in a humidified atmosphere with 5% CO2.
PFC assay. The cultures were assayed for antigen-specific antibody-secreting
cells by a slide modification of the Jerne hemolytic plaque-forming cell (PFC)
assay, using TNP or vaccine-coupled SRBC as described by us earlier (18, 25).
Briefly, 0.5 ml of packed SRBC was coupled with 1.0 mg of the 23-valent
Pnu-Imune vaccine, using 0.1% chromium chloride, by rotating the tube gently
for 10 min at room temperature (18). The vaccine-coupled SRBC were washed
three times with normal saline and were used on the same day. The clarity of the
plaques was enhanced by adding 0.6% polyethylene glycol 8000 to the plaquing
mixture. Previously we demonstrated that these vaccine-coupled SRBC were
;50% as efficient as SRBC coupled with individual capsular pneumococcal PS in
detecting the PFC response to any particular component of the vaccine. Also, we
showed that both the in vitro and in vivo PFC responses were mainly against the
capsular PS and that the response to the contaminating cell wall PS was esti-
mated to be 10 to 14% of the response measured with the vaccine-coupled
SRBC. TNP-SRBC were prepared by reacting SRBC with 2,4,6-trinitrobenzene
sulfonic acid at room temperature, and any unreacted reagent was removed by
treating washed TNP-SRBC with glycylglycine.
The cultures were assayed for PFC by using both vaccine-coupled SRBC and
unconjugated SRBC. Any response measured with uncoupled SRBC was sub-
tracted from the values obtained with vaccine-coupled erythrocytes. Results are
represented as means 6 standard errors (SE) of triplicate samples.
RESULTS
Unresponsiveness of spleen cells from old mice to Pnu-
Imune vaccine in vitro.Our earlier studies showed that neither
spleen nor lymph node cells from old mice responded to an in
vivo challenge with the 23-valent Pnu-Imune vaccine (18). To
understand the cellular basis of this unresponsiveness, we
studied these responses in vitro, using a culture system de-
scribed by us recently (17). When spleen cells from young and
old mice were cultured in vitro with an optimal dose of the
vaccine, spleen cells from young but not old mice generated
vaccine-specific PFC (Fig. 1). In comparison with the young
mice, the vaccine response declined by about 70% by 10 to 12
months of age, and at 20 to 22 months of age, only 10% of the
response remained. In agreement with this finding, our previ-
ous in vivo studies showed that 22-month-old mice did not
respond well to the vaccine (18). To be certain that this de-
FIG. 1. Effect of age on the immune response to vaccine. Spleen cells (2 3
106) from BALB/c mice of various age groups were cultured in vitro as described
in Materials and Methods with 0.0115 mg of Pnu-Imune vaccine for 5 days, and
the vaccine-specific antibody-forming cells were measured by using Pnu-Imune
coupled SRBC. Two to three mice were used for each age group, and the results
from one of two similar experiments are shown. The pattern of age-dependent
changes in the response remained the same when 0.0015 or 0.115 mg of vaccine
was used as the immunogen. The values represent the arithmetic means of
responses of triplicate cultures, and the bars represent SE values.
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crease in vaccine response was not due to a change in the dose
response or in kinetics, spleen cells from old mice were cul-
tured with various doses of the vaccine for various periods of
time. As shown in Fig. 2A, spleen cells from old mice did not
respond to any dose of the vaccine whereas the young mouse-
derived cells responded well. Furthermore, old mouse spleen
cells did not respond to the vaccine at any tested time after
initiation of culture (Fig. 2B). The spleen cells from old mice
responded well to other TI antigens such as TNP-Brucella
abortus and TNP-Ficoll (Fig. 2B).
Absence of vaccine response in old mice was not due to
T-cell-mediated suppression. Although the PFC response to
pneumococcal PS is T-cell independent (3, 18), several inves-
tigators have shown the PS response to be regulated by sup-
pressor T cells (3, 4, 7, 8, 54). To determine if the vaccine
unresponsiveness in old mice was due to such T-cell-mediated
suppressive influences, T cells from young and old mice were
depleted by treatment with anti-T-cell-specific MAbs and com-
plement once or twice. As shown in Fig. 3, elimination of T
cells by single or double treatment did not reduce the PFC
response from young mice spleen cells, in agreement with the
T-cell-independent nature of this response as reported by us
earlier (18). Moreover, the T-cell depletion failed to restore
responsiveness to the vaccine in spleen cells from old mice.
The T-cell-depleted spleen cells from young and old mice
responded to TNP-BA as well as the untreated spleen cells
(data not shown). As described in Materials and Methods, the
T-cell depletion protocol reduced the proliferative response to
the T-cell mitogen concanavalin A by 95 to 99%. Also, in
young and aged mice, this treatment reduced the PFC re-
sponse to TNP-Ficoll, consistent with the previously reported
T-cell-dependent nature of this TI-2A antigen (15, 17, 29, 33).
Splenic accessory cells from young mice restore the vaccine
response of old mice. It is conceivable that old mouse spleen
cells are deficient in a cell type that is necessary for the vaccine
response and is present in the young mice in adequate num-
bers. Therefore, various numbers of irradiated young mouse
spleen cells were added to the cultures of spleen cells from old
mice plus vaccine. As shown in Fig. 4, irradiated young mouse
spleen cells helped the old mouse spleen cultures to respond to
the vaccine very well, suggesting that old mouse spleen is
deficient in a splenic accessory cell. Interestingly, addition of
FIG. 2. Kinetics of in vitro immune response to the vaccine. (A) Spleen cells
from young (3 to 5 month-old) and old (24-month-old) BALB/c mice were
cultured for 5 days with various doses of the vaccine. (B) Spleen cells from old
mice (22 to 24 months) were cultured with various doses of vaccine, TNP-BA, or
TNP-Ficoll for the indicated periods of time. The vaccine-specific PFC responses
are measured as described in Materials and Methods. The values represent
arithmetic means 6 SE of triplicate cultures. Results from one of three similar
experiments are shown.
FIG. 3. Role of T cells in the vaccine response. T cells were removed by
treating young or old mouse-derived spleen cells with a cocktail of anti-T-cell
antibodies and complement either once or twice (bars with 1x and 2x) as de-
scribed in Materials and Methods. The T-cell-depleted spleen cells were cultured
with 0.0115 mg of the vaccine for 5 days, at which time the number of vaccine-
specific PFC was measured as described above. This experiment was repeated at
least three times with similar results. In all experiments, the treated and un-
treated spleen cells were also cultured with a 0.00115-mg dose of the vaccine with
a similar outcome. When corrected for B-cell numbers, the differences between
the responses of untreated and T-cell-depleted (1x or 2x) young spleen cells were
not statistically significant (P . 0.07). For old mouse spleen cells, the responses
were very small but the differences were statistically significant (P 5 0.007 and
0.02, respectively, for once- and twice-T-cell-depleted cells).
FIG. 4. Splenic accessory cells from young or old mice restore the antibody
response to Pnu-Imune vaccine. Spleen cells from old mice were cultured with
0.0115 mg of the vaccine with various numbers of irradiated spleen cells from
young (4 to 5 month-old) or old (20- to 24-month-old) mice for 5 days. The
adherent cells were removed from the young mouse spleen either by incubation
on plastic petri dishes or by passage through Sephadex G-10 columns. The mean
values of vaccine-specific PFC responses from triplicate cultures are shown along
with the SE bars. Similar results were obtained with all doses of the vaccine
tested, but the results with 0.0115 mg of the vaccine are shown. Representative
results from an experiment that was repeated three times are shown.
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irradiated old mouse spleen cells also restored the vaccine
responsiveness of unirradiated cells from old mice (Fig. 4).
Control experiments showed that the irradiated young or old
mouse spleen cells did not respond by themselves to the vac-
cine. Larger numbers of the accessory cells from old mice were
needed to induce as good a response as for the young mouse-
derived irradiated spleen cells. Thus, the deficiency appeared
to be a quantitative one in old mice. Removal of T cells from
the irradiated spleen cells did not affect their ability to recon-
stitute the vaccine response of old mice in these in vitro cul-
tures (data not shown).
To determine if macrophage-like adherent cells are neces-
sary to detect accessory function in the spleen cells, adherent
cells were depleted from young mouse spleen cells by adher-
ence on plastic or by passage through a Sephadex G-10 column
(Fig. 4). Results presented in Fig. 4 demonstrated that the
critical cell necessary for reconstitution of the vaccine response
was an adherent cell. Notably, these adherent cells were re-
moved more efficiently by Sephadex G-10 column than by
adherence to plastic (Fig. 4). Similarly, passage of old mouse
spleen cells through the Sephadex G-10 column reduced their
ability to reconstitute the vaccine response of the old mice
(data not shown). To further characterize the accessory cells,
they were purified by overnight adherence to plastic and the
number of phagocytic cells was determined by their ability to
take up fluorescent latex beads, using a flow cytometer. As
shown in Table 1, the adherent cells were enriched for cells
that take up the latex beads. Also, the adherent cells were
enriched for cells that express the macrophage-specific Mac-1
antigen (Table 1). The numbers of Mac-1-positive cells was
slightly less than the number of cells that took up latex beads,
which may be because of the reported loss of Mac-1 from some
activated macrophages (31). In accordance with this finding, up
to 15% of the Mac-1-negative cells expressed F4/80, another
macrophage-specific marker. However, most of the remaining
(;40%) adherent cells were found to be B cells, which should
not contribute to the vaccine response since they were always
irradiated. In every experiment, we verified that the irradiated
splenic accessory cells (from young or old mice) did not re-
spond to the vaccine on their own but restored the vaccine
response of the spleen cells from aged mice.
Cytokines can substitute for accessory cell function. The
function of splenic macrophages can be provided by IL-1 in a
variety of TI-antigen responses, including the PFC response to
the vaccine (6, 17, 24, 25, 40, 50). Also, macrophages from old
mice have been shown to produce less IL-1 than their young
counterparts (26). Therefore, spleen cells from old mice were
cultured with vaccine in the presence of IL-1, which also per-
mitted these cells to respond to the vaccine extremely well
(Fig. 5A). Notably, a T-cell line-derived supernatant (TGG
Sup), which contained IL-4, IL-6, and IL-5 but not IL-2, sup-
ported a vaccine response from spleen cells from old mice.
When tested individually, IL-5 (Fig. 5A) and IL-4 (Fig. 5B)
were very effective in restoring the vaccine response from aged
mice. Neither IL-2 (a cytokine that is deficient in the aged) nor
IL-6 (a cytokine that is elevated in old mice) induced a vaccine
response in old mouse spleen cells. Importantly, when tested
with young mice, both IL-2 and IL-6 did not inhibit the vaccine
response at all doses tested (1 to 100 U/ml). Thus, changes in
these T-cell-derived cytokines with age are not likely to be the
primary cause of the decreased vaccine response in the old
mice.
Next we tested if cytokines can act on B cells directly and
induce a vaccine-specific response. B cells were purified by
removing macrophages by a combination of plastic adherence
and passage through Sephadex G-10 column, while the T cells
were eliminated by treatment with three anti-T-cell antibodies
plus complement as described in Materials and Methods. As
shown in Fig. 6, the highly purified B cells responded poorly to
the vaccine even in the presence of IL-5. Although, the mag-
nitude of response in the presence of IL-1 alone was higher, it
was still less than that obtained in the presence of both cyto-
kines. The PFC responses in the presence of the individual
cytokines (IL-1 and IL-5) were found to be variable, whereas
the response in the presence of both cytokines was always
substantially high in six different experiments.
DISCUSSION
These studies have shown that the in vivo unresponsiveness
of aged mice to Pnu-Imune vaccine can be reproduced in vitro.
FIG. 5. Effects of lymphokines on the PFC response of aged mouse spleen
cells to the vaccine. Spleen cells from old mice were cultured with 0.0115 mg of
the vaccine in the presence of an optimal dose of each cytokine and the vaccine.
(A) TGG Sup- and HeLa cell-derived recombinant IL-5 were used at 1:100
dilution of the stock. Recombinant IL-1 and IL-2 were used at 10 and 50 U/ml,
respectively. The mean values of vaccine-specific PFC responses from triplicate
cultures are shown along with the SE values. (B) Recombinant IL-4 was used at
the indicated concentrations. All other conditions were the same as for panel A.
Results from representative experiments that were repeated four (A) and two
(B) times are shown.
TABLE 1. Purity of adherent cells assessed by their
phagocytic capacitya
Cells % Mac-1positive
% Cells containing
latex beads
Spleen 6 9.5
Nonadherent 1.2 5.3
Adherent 40.7 54.5
a Various cell populations (106), prepared as described in Materials and Meth-
ods, were incubated with 1.0 ml of latex beads or stained with anti-Mac-1 MAb.
The cells were washed as described in Materials and Methods and then analyzed
on a FACScan flow cytometer. Representative results from one of three such
experiments are shown.
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Cell separation analysis demonstrated that the lack of response
was not due to T-cell-mediated suppressive influences but was
primarily due to a deficiency in a splenic adherent accessory
cell. Also, these data suggested that B cells in the aged mice did
not have an intrinsic defect in their ability to respond to the
vaccine. These observations are consistent with two earlier in
vivo observations. First, Smith found that the numbers of PS-
binding B cells were not reduced in aged mice in spite of a low
antibody response (51). Second, MPL, an agent that has been
shown to activate macrophages, restored vaccine responsive-
ness in old mice (18). In vitro, young and aged mice responded
similarly to TNP-BA, a TI-1 antigen which has mitogenic and
macrophage activating properties which may overcome such
defects in aged mouse B-cell responses (6). We found that the
effect of age on in vitro responses to TNP-Ficoll was variable,
with only a 20 to 30% decrease (data not shown). Previous
studies found that the in vivo responses to TNP-Ficoll are
reduced in the aged, presumably as a result of regulation by
anti-idiotypes, which may not be made efficiently in short-term
in vitro cultures, explaining a lack of age-associated defect in
vitro (21).
Baker et al. also found that MPL enhanced the immune
response to type III pneumococcal PS, presumably as a result
of its ability to inactivate a suppressor T cell (4), which can
explain its adjuvanticity for the vaccine response in the aged
mice (18). As shown here, T-cell-mediated suppression was not
the only cause of a poor response of aged mice to pneumo-
coccal PS, since T-cell depletion failed to induce a vaccine
response from aged mouse B cells.
Interestingly, the accessory cell defect was only quantitative,
since irradiated spleen cells from old mice were also effective
in eliciting a vaccine response from old mice but a larger
number of such old mouse accessory cells than of the young
mouse-derived spleen cells was needed. The ability of IL-1, an
accessory cell-derived cytokine, to replace the need for these
additional accessory cells suggests that the accessory cells from
aged mice may be deficient in IL-1 secretion, and such a de-
ficiency has been reported (26). This IL-1-correctable acces-
sory cell defect for the vaccine response was similar to an
antigen-presenting cell defect, whereby splenic macrophages
were specifically unable to stimulate a syngeneic mixed lym-
phocyte reaction in aged mice unless exogenous IL-1 was
added (46). Direct measurements of IL-1 secretion are needed
to determine if the accessory cells from aged mice produce less
of the cytokine per cell or if there is a reduction in the total
number of cells that produce normal levels of the cytokine.
Previous studies concerning a decline in IL-1 production in
aged mice did not distinguish between these two possibilities.
The ability of IL-5 to augment the vaccine response in the
aged mice was surprising because the T-cell production of the
lymphokines IL-4, IL-5, and IL-6, characteristically made by
Th2 cells, was reported to be elevated in old mice (12, 14).
Notably, Daynes and Araneo reported that IFN-g, a Th1-
derived lymphokine, was also elevated, while production of
another Th1-dependent lymphokine, IL-2, was severely re-
duced in the aged mice in comparison with young mice (12). As
shown by us earlier and in this study, the vaccine response was
very low in aged mice both in vitro and in vivo. The low
response to the vaccine in vivo may be due to the increase in
the levels of IFN-g, which we had previously shown to be
inhibitory to the vaccine response (17). Hence, the vaccine
response may be low in spite of elevated levels of IL-5, as a
result of the inhibitory effects of IFN-g in vivo. The in vitro
cultures showed that in addition to such possible inhibitory
effects by Th1-derived cytokines, an accessory cell deficiency
also existed in old mice, since addition of splenic adherent cells
but not removal of T cells by complement-mediated lysis re-
stored responsiveness. However, we cannot rule out the pos-
sibility that non-T cells such as natural killer cells produce
IFN-g in vitro in T-cell-depleted cells. We are attempting to
address this issue by using specific MAbs to block the effects of
IFN-g and by depleting natural killer cells.
Daynes and colleagues have postulated that the phenome-
non of immune senescence may be related to an age-associated
decrease in the production of the hormone DHEA, since it
appears to modulate the patterns of cytokine secretion by T
cells, leading to a decrease in IL-2 and increase an in IL-4,
IL-5, IL-6, and IFN-g (12–14). These workers successfully al-
tered the pattern of cytokine secretion by T cells from aged
mice as well as the immune responses to T-cell-dependent
antigens following acute or chronic therapy with DHEA (12,
14). Our ability to reconstitute the in vivo vaccine response by
acute treatment with DHEA is also consistent with a DHEA-
induced decrease in IFN-g (16). However, the accessory cell
deficiency demonstrated here raises the question of whether
the primary effect of DHEA is on T cells or accessory cells.
Recently we have been able to reproduce the effect of DHEA
by restoring the vaccine response from old mouse spleen cells
in vitro (our unpublished observations), and therefore the site
of action of the hormone can now be determined in vitro.
It is interesting that the spleen cells from aged mice resem-
bled peripheral lymph node cells from young mice, which also
did not make an antibody response to the vaccine or to all TI-2
antigens studied, in vivo as well as in vitro (6, 17, 18, 22–25). In
both situations, elimination of T cells did not restore the vac-
cine response, suggesting that T-cell-mediated suppression was
not the primary cause of unresponsiveness (6, 17, 23, 25).
Furthermore, in both cases, splenic accessory cells reconsti-
tuted the response and the accessory cell defect was a quanti-
tative one. In the young mouse-derived lymph node as well as
in the old mouse spleen, both IL-1 and IL-5 substituted very
well for the splenic accessory cells in eliciting a vaccine re-
sponse (6, 17). Lymph nodes do not appear to develop the
accessory function to adequate levels at any time in the life of
the mouse, since both young and old mice cannot respond to a
subcutaneous challenge with the vaccine (18). The spleen at-
tains peak levels of such accessory cells by 3 to 4 months of age,
when the vaccine responses are maximum, and their function
begins to decline after about 10 to 12 months of age, resulting
in a progressive loss of the vaccine response.
Our data suggest that IL-1 and IL-5 act directly on B cells
FIG. 6. IL-1 and IL-5 can induce a vaccine-specific PFC response from pu-
rified B cells from old mice. Adherent and T-cell-depleted B cells were purified
as described in Materials and Methods. Recombinant IL-1 and IL-5 were used at
25 and 10 U/ml, respectively. All other experimental conditions are the same as
for Fig. 5. Results are representative of three experiments with similar results.
The SE bars are too small to be seen.
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from aged mice but not by stimulating T cells or some other
accessory cells to produce cytokines that can augment the
B-cell response. However, we cannot rule out the possibility
that they inhibit the production of the inhibitory cytokine
IFN-g by non-T cells such as natural killer cells. Studies by
Pike and Nossal (40) and by Sinha et al. (50), with TNP-Ficoll-
responsive B cells in single-cell cultures, showed that IL-1 can
act directly on TI-2A antigen-responsive B cells. Also, our
studies showed that TNP-Ficoll can induce a proliferative sig-
nal in lymph node B cells but not differentiation, a step facil-
itated by the addition of IL-1 or IL-5 (6, 24). Since the vaccine
behaves like a TI-2 antigen, it is not surprising that the cyto-
kines act directly on B cells to induce a vaccine-specific PFC
response. Currently we are determining the role of IFN-g in
the vaccine response, using specific MAbs.
The accessory cell deficiency demonstrated here suggests
that the efficacy of the vaccine may be increased for the elderly
population by exploring adjuvants that can increase IL-1 pro-
duction in vivo. Agents that can counteract the inhibitory ef-
fects of IFN-g may also be useful in augmenting vaccine effi-
cacy in the elderly. In accordance with this observation,
preliminary studies showed that the vaccine responses of the
aged mice can be enhanced by supplementation with IL-10, a
cytokine that can antagonize IFN-g production (29a, 34). Also,
strategies to make the vaccine T-cell dependent may not be as
important for older individuals (6, 38, 44), since the necessary
T-cell-derived cytokine, IL-5, is already high in aged mice but
is unable to help the vaccine response. In summary, these
studies showed for the first time that the hyporesponsiveness of
older animals to pneumococcal PS vaccine is due to an acces-
sory cell deficiency and have suggested strategies to increase
the vaccine efficacy for this population.
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